FP7H2020HORIZON
Abbvie Deutschland GmbH & Co KG
- Country
- DEGermany
- Defence projects
- 0
- Projects, all programmes
- 14
- As coordinator
- 0
- EU contribution (CORDIS)
- EUR 260,539
- Active
- 2009 to 2024
Projects
14 projects, newest first
| Project | Programme | Year | Role | EU contribution |
|---|---|---|---|---|
| MC4DDMacrocycles for Drug Discovery | HORIZON | 2024 | Participant | EUR 260,539 |
| AI-PROGNOSISArtificial intelligence-based Parkinson’s disease risk assessment and prognosis | HORIZON | 2023 | Participant | EUR 0 |
| GUIDE.MRDGUIding multi-moDal thErapies against MRD by liquid biopsies - GUIDE.MRD | HORIZON | 2023 | Associated partner | EUR 0 |
| IMPRiNDInhibiting Misfolded protein PRopagation in Neurodegenerative Diseases - Sofia ref.: 116060 | H2020 | 2017 | Participant | EUR 0 |
| TransQSTTranslational quantitative systems toxicology to improve the understanding of the safety of medicines - Sofia: 116030 | H2020 | 2017 | Participant | EUR 0 |
| IB4SD-TRISTANImaging Biomarkers (IBs) for Safer Drugs: Validation of Translational Imaging Methods in Drug Safety Assessment - Sofia ref.: 116106 | H2020 | 2017 | Participant | EUR 0 |
| ADAPTEDAlzheimers Disease Apolipoprotein Pathology for Treatment Elucidation and Development - Sofia ref.: 115975 | H2020 | 2016 | Participant | EUR 0 |
| PHAGOInflammation and AD: modulating microglia function focussing on TREM2 and CD33 - Sofia ref.: 115976 | H2020 | 2016 | Participant | EUR 0 |
| COMPACTCollaboration on the Optimisation of Macromolecular Pharmaceutical Access to Cellular Targets | FP7 | 2012 | Participant | Not stated |
| STEMBANCCStem cells for Biological Assays of Novel drugs and prediCtive toxiCology (StemBANCC) | FP7 | 2012 | Participant | Not stated |
| ORBITOOral biopharmaceutics tools | FP7 | 2012 | Participant | Not stated |
| MIP-DILIMechanism-Based Integrated Systems for the Prediction of Drug-Induced Liver Injury | FP7 | 2012 | Participant | Not stated |
| NEWMEDSNovel Methods leading to New Medications in Depression and Schizophrenia | FP7 | 2009 | Participant | Not stated |
| EUROPAINUnderstanding chronic pain and improving its treatment | FP7 | 2009 | Participant | Not stated |
The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them (reuse under Commission Decision 2011/833/EU).
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.
Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.